Novel compounds of the general formula (I), the use of these compounds as pharmaceutical compositions, pharmaceutical compositions comprising the compounds and methods of treatment employing these compounds and compositions. The present compounds are activators of PPARδ and should be useful for treating conditions mediated by the same.
一般式(I)的新化合物,这些化合物作为制药组合物的用途,包括这些化合物的制药组合物和使用这些化合物和组合物的治疗方法。这些化合物是
PPARδ的激活剂,应该对通过
PPARδ介导的疾病治疗有用。